Heberprot-P

recombinant human epidermal growth factor · Labiofam

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Heberprot-P, covering 2017-08-04 to 2017-08-04. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Heberprot-P® in Patients With Advanced Diabetic Foot Ulcer in Dasman Diabetes Institute.